Evidence map›Paper›PMID 25002579›Full record

ArticleThe Journal of biological chemistry2014

The combined structural and kinetic characterization of a bacterial nitronate monooxygenase from Pseudomonas aeruginosa PAO1 establishes NMO class I and II.

Francesca Salvi, Johnson Agniswamy, Hongling Yuan, Ken Vercammen, Rudy Pelicaen, Pierre Cornelis, Jim C Spain, Irene T Weber, Giovanni Gadda

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Nitroalkane oxidase: Structure and mechanism.Archives of biochemistry and biophysics · 2017
    Review
  8. Draft genome sequence ofGenomics data · 2016
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesca SalviFrom the Departments of Chemistry.
Johnson AgniswamyBiology.
Hongling YuanFrom the Departments of Chemistry.
Ken Vercammenthe Department of Bioengineering Sciences, Vrije Universiteit Brussel, Belgium, and the Department of Structural Biology Brussels, VIB, Pleinlaan 2, 1050 Brussels, Belgium.
Rudy Pelicaenthe Department of Bioengineering Sciences, Vrije Universiteit Brussel, Belgium, and the Department of Structural Biology Brussels, VIB, Pleinlaan 2, 1050 Brussels, Belgium.
Pierre Cornelisthe Department of Bioengineering Sciences, Vrije Universiteit Brussel, Belgium, and the Department of Structural Biology Brussels, VIB, Pleinlaan 2, 1050 Brussels, Belgium.
Jim C Spainthe School of Civil and Environmental Engineering, Georgia Institute of Technology, Atlanta, Georgia 30302.
Irene T WeberFrom the Departments of Chemistry, Biology, Center for Biotechnology and Drug Design, iweber@gsu.edu.
Giovanni GaddaFrom the Departments of Chemistry, Biology, Center for Biotechnology and Drug Design, Center for Diagnostics and Therapeutics, Georgia State University, Atlanta, Georgia 30302, ggadda@gsu.edu.

Funding

SciBay: A New Methodology for Scientific Collaboration and Gene Function DetermiRC2GM092602 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI KASIF, SIMON, ROBERTS, RICHARD J · 2009 to 2010
$4.0M
NIGMS NIH HHS 1RC2GM092602-01NIGMS NIH HHS RC2 GM092602
6 · The paper itself

Abstract

Nitronate monooxygenase (NMO) oxidizes the mitochondrial toxin propionate 3-nitronate (P3N) to malonate semialdehyde. The enzyme has been previously characterized biochemically in fungi, but no structural information is available. Based on amino acid similarity 4,985 genes are annotated in the GenBank(TM) as NMO. Of these, 4,424 (i.e. 89%) are bacterial genes, including several Pseudomonads that have been shown to use P3N as growth substrate. Here, we have cloned and expressed the gene pa4202 of Pseudomonas aeruginosa PAO1, purified the resulting protein, and characterized it. The enzyme is active on P3N and other alkyl nitronates, but cannot oxidize nitroalkanes. P3N is the best substrate at pH 7.5 and atmospheric oxygen with k(cat)(app)/K(m)(app) of 12 × 10(6) M(-1) s(-1), k(cat)(app) of 1300 s(-1), and K(m)(app) of 110 μm. Anerobic reduction of the enzyme with P3N yields a flavosemiquinone, which is formed within 7.5 ms, consistent with this species being a catalytic intermediate. Absorption spectroscopy, mass spectrometry, and x-ray crystallography demonstrate a tightly, non-covalently bound FMN in the active site of the enzyme. Thus, PA4202 is the first NMO identified and characterized in bacteria. The x-ray crystal structure of the enzyme was solved at 1.44 Å, showing a TIM barrel-fold. Four motifs in common with the biochemically characterized NMO from Cyberlindnera saturnus are identified in the structure of bacterial NMO, defining Class I NMO, which includes bacterial, fungal, and two animal NMOs. Notably, the only other NMO from Neurospora crassa for which biochemical evidence is available lacks the four motifs, defining Class II NMO.

Indexed as

Amino Acid SequenceCrystallizationElectrophoresis, Polyacrylamide GelKineticsMixed Function OxygenasesMolecular Sequence DataProtein ConformationPseudomonas aeruginosaSequence Homology, Amino AcidSubstrate SpecificityMixed Function Oxygenases3-NitropropionateEnzyme CatalysisEnzyme StructureFlavoproteinNitronate MonooxygenaseOxidoreductasePropionate 3-NitronatePseudomonas Aeruginosa (P. Aeruginosa)TIM BarrelToxin

Identifiers

PMID25002579
PMCPMC4156069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.